Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Soleno Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Soleno Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Egalet Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Egalet Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intracellular Th Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intracellular Th Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Prothena Corporation plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Prothena Corporation plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Cancer Genetics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Cancer Genetics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Jaguar Health Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Jaguar Health Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Reata Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Reata Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Regulus Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Regulus Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Affimed NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affimed NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Otonomy Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otonomy Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

PTC Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

PTC Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Acceleron Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acceleron Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adverum Biotechnologies Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adverum Biotechnologies Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

IVERIC bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

IVERIC bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Pieris Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Pieris Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ultragenyx Pharmaceutical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ultragenyx Pharmaceutical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

DarioHealth Corp Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

DarioHealth Corp Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Flex Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Flex Pharma Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Fortress Biotech Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Fortress Biotech Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NantKwest Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NantKwest Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Caredx Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Caredx Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Crispr Therapeutics AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Crispr Therapeutics AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Foamix Pharmaceuticals Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Foamix Pharmaceuticals Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Intercept Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Intercept Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Recro Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Recro Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aptevo Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aptevo Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sesen Bio, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sesen Bio, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

NanoString Technologies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

NanoString Technologies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

SCYNEXIS, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

SCYNEXIS, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

vTv Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

vTv Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Argos Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Argos Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

INC Research Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

INC Research Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Proteostasis Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Proteostasis Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

TRACON Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

TRACON Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Corbus Pharmaceuticals Holding Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Corbus Pharmaceuticals Holding Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Enanta Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Enanta Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Epizyme Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Epizyme Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AC Immune Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AC Immune Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Veracyte Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Veracyte Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Horizon Pharma PLC Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Horizon Pharma PLC Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Retrophin Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Retrophin Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Supernus Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Supernus Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adaptimmune Therapeutics Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adaptimmune Therapeutics Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Clearside Biomedical Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Clearside Biomedical Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Organovo Holdings Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Organovo Holdings Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

CytomX Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

CytomX Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Insys Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Insys Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Miragen Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Miragen Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Onconova Therapeutics Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Onconova Therapeutics Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AcelRx Pharmaceuticals Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AcelRx Pharmaceuticals Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1